Kestra Medical Technologies (KMTS) Net Income towards Common Stockholders (2024 - 2026)

Kestra Medical Technologies (KMTS) has 3 years of Net Income towards Common Stockholders data on file, last reported at -$34.2 million in Q1 2026.

• Net Income towards Common Stockholders for Q1 2026 came in at -$34.2 million, down 37.58% year-over-year; the trailing twelve-month figure through Jan 2026 was -$148.1 million (down 55.8% YoY), and the FY2025 annual result was -$126.1 million, down 25.08% from the prior year.
• Net Income towards Common Stockholders eased to -$34.2 million in Q1 2026 per KMTS's latest filing, from -$32.8 million in the prior quarter.
• Over five years, Net Income towards Common Stockholders peaked at -$22.3 million in Q3 2024 and troughed at -$55.3 million in Q2 2025.
• A 3-year average of -$29.6 million and a median of -$24.8 million in 2025 frame the typical range for Net Income towards Common Stockholders.
• On a YoY basis, Net Income towards Common Stockholders climbed as much as 5.98% in 2025 and fell as far as 127.96% in 2025.
• A 3-year view of Net Income towards Common Stockholders shows it stood at -$23.7 million in 2024, then sank by 38.39% to -$32.8 million in 2025, then retreated by 4.21% to -$34.2 million in 2026.
• Business Quant data shows KMTS's Net Income towards Common Stockholders at -$34.2 million in Q1 2026, -$32.8 million in Q4 2025, and -$25.8 million in Q3 2025.